These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 14692963)

  • 1. Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs.
    King KE; Shirey RS; Thoman SK; Bensen-Kennedy D; Tanz WS; Ness PM
    Transfusion; 2004 Jan; 44(1):25-9. PubMed ID: 14692963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Prestorage Leukoreduction on the Rate of Febrile Nonhemolytic Transfusion Reactions to Red Blood Cells in a Tertiary Care Hospital.
    Rajesh K; Harsh S; Amarjit K
    Ann Med Health Sci Res; 2015; 5(3):185-8. PubMed ID: 26097760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of febrile but not allergic reactions to RBCs and platelets after conversion to universal prestorage leukoreduction.
    Paglino JC; Pomper GJ; Fisch GS; Champion MH; Snyder EL
    Transfusion; 2004 Jan; 44(1):16-24. PubMed ID: 14692962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of prestorage WBC reduction on the rates of febrile nonhemolytic transfusion reactions to platelet concentrates and RBC.
    Yazer MH; Podlosky L; Clarke G; Nahirniak SM
    Transfusion; 2004 Jan; 44(1):10-5. PubMed ID: 14692961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prestorage universal WBC reduction of RBC units does not affect the incidence of transfusion reactions.
    Uhlmann EJ; Isgriggs E; Wallhermfechtel M; Goodnough LT
    Transfusion; 2001 Aug; 41(8):997-1000. PubMed ID: 11493730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of prestorage vs poststorage leukoreduction on the rate of febrile nonhemolytic transfusion reactions to platelets.
    Wang RR; Triulzi DJ; Qu L
    Am J Clin Pathol; 2012 Aug; 138(2):255-9. PubMed ID: 22904138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of reactions after exclusive transfusion of white cell-reduced cellular blood components.
    Dzieczkowski JS; Barrett BB; Nester D; Campbell M; Cook J; Sugrue M; Andersen JW; Anderson KC
    Transfusion; 1995 Jan; 35(1):20-5. PubMed ID: 7998063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of leukocyte-reduction on the transfusion reactions to red blood cells concentrates].
    Mukagatare I; Monfort M; de Marchin J; Gerard C
    Transfus Clin Biol; 2010 Feb; 17(1):14-9. PubMed ID: 20106700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Leukoreduction and Premedication With Acetaminophen and Diphenhydramine in Minimizing Febrile Nonhemolytic Transfusion Reactions and Allergic Transfusion Reactions During and After Blood Product Administration: A Literature Review With Recommendations for Practice.
    Duran J; Siddique S; Cleary M
    J Pediatr Oncol Nurs; 2014 Jul; 31(4):223-229. PubMed ID: 24794886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feeling the burn: the significant burden of febrile nonhemolytic transfusion reactions.
    Cohen R; Escorcia A; Tasmin F; Lima A; Lin Y; Lieberman L; Pendergrast J; Callum J; Cserti-Gazdewich C
    Transfusion; 2017 Jul; 57(7):1674-1683. PubMed ID: 28369916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of buffy coat reduction on the severity of febrile nonhemolytic transfusion reactions with red cell components.
    Singh L; Prinja N; Jain A; Sharma RR; Marwaha N
    Asian J Transfus Sci; 2023; 17(1):69-73. PubMed ID: 37188007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of leukoreduction on the acute transfusion-related complication rate in 455 dogs receiving 730 packed RBCs: 2014-2017.
    Davidow EB; Montgomery H; Mensing M
    J Vet Emerg Crit Care (San Antonio); 2022 Jul; 32(4):479-490. PubMed ID: 35043550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of leukoreduced red blood cell products is associated with fewer infectious complications in trauma patients.
    Friese RS; Sperry JL; Phelan HA; Gentilello LM
    Am J Surg; 2008 Jul; 196(1):56-61. PubMed ID: 18513694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized double-blinded clinical trial on acute transfusion reactions in dogs receiving leukoreduced versus nonleukoreduced packed red blood cells.
    Radulescu SM; Skulberg R; McDonald C; Chan DL; Humm K
    J Vet Intern Med; 2021 May; 35(3):1325-1332. PubMed ID: 33960540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of reactions after transfusion of cellular blood components that are white cell reduced before storage.
    Federowicz I; Barrett BB; Andersen JW; Urashima M; Popovsky MA; Anderson KC
    Transfusion; 1996 Jan; 36(1):21-8. PubMed ID: 8607149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfusion-associated adverse reactions (TAARs) and cytokine accumulations in the stored blood components: the impact of prestorage versus poststorage leukoreduction.
    Chang CC; Lee TC; Su MJ; Lin HC; Cheng FY; Chen YT; Yen TH; Chu FY
    Oncotarget; 2018 Jan; 9(4):4385-4394. PubMed ID: 29435110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypothermic storage of leukoreduced red blood cells for greater than 21 days is a safe alternative to irradiation.
    Mykhailova O; Turner TR; Olafson C; Howell A; Nahirniak SN; Wizniak J; Gerges HYN; Baldwin T; Clarke G; Acker JP
    Transfusion; 2021 Apr; 61(4):1247-1257. PubMed ID: 33481275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of acute transfusion reactions in a teaching hospital of Sikkim: A hemovigilance initiative.
    Sharma DK; Datta S; Gupta A
    Indian J Pharmacol; 2015; 47(4):370-4. PubMed ID: 26285707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of transfusion-related adverse reactions per patient reflects the potential risk of transfusion therapy in Japan.
    Kato H; Uruma M; Okuyama Y; Fujita H; Handa M; Tomiyama Y; Shimodaira S; Kurata Y; Takamoto S
    Am J Clin Pathol; 2013 Aug; 140(2):219-24. PubMed ID: 23897258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of adverse reaction rates for PAS C versus plasma platelet units.
    Cohn CS; Stubbs J; Schwartz J; Francis R; Goss C; Cushing M; Shaz B; Mair D; Brantigan B; Heaton WA
    Transfusion; 2014 Aug; 54(8):1927-34. PubMed ID: 24735171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.